(Q37896548)

25 August 2017

1 reference

title

Biomarkers in dementia with Lewy bodies: a review (English)

1 reference

dementia with Lewy bodies

25 August 2017

0 references

0 references

1 reference

3

1 reference

25 August 2017

Michael Firbank

2

0 references

author name string

Namrta Sinha

series ordinal

1

1 reference

25 August 2017

language of work or name

English

0 references

publication date

1 July 2011

1 reference

International Journal of Geriatric Psychiatry

25 August 2017

published in

1 reference

25 August 2017

volume

27

1 reference

25 August 2017

issue

5

1 reference

25 August 2017

page(s)

443-453

1 reference

Frequency and case identification of dementia with Lewy bodies using the revised consensus criteria.

25 August 2017

cites work

1 reference

Autonomic dysfunction in dementia.

21 January 2018

1 reference

MRI study of caudate nucleus volume in Parkinson's disease with and without dementia with Lewy bodies and Alzheimer's disease.

21 January 2018

1 reference

Differences in neuropathologic characteristics across the Lewy body dementia spectrum.

21 January 2018

1 reference

A comparison of medial and lateral temporal lobe atrophy in dementia with Lewy bodies and Alzheimer's disease: magnetic resonance imaging volumetric study.

21 January 2018

1 reference

Volumetric MRI study of the caudate nucleus in patients with dementia with Lewy bodies, Alzheimer's disease, and vascular dementia

21 January 2018

1 reference

Gray matter atrophy in Parkinson disease with dementia and dementia with Lewy bodies.

21 January 2018

1 reference

CSF amyloid-beta-peptides in Alzheimer's disease, dementia with Lewy bodies and Parkinson's disease dementia

21 January 2018

1 reference

Validation of amyloid-beta peptides in CSF diagnosis of neurodegenerative dementias.

21 January 2018

1 reference

Cortical cholinergic function is more severely affected in parkinsonian dementia than in Alzheimer disease: an in vivo positron emission tomographic study

21 January 2018

1 reference

CSF Mg and Ca as diagnostic markers for dementia with Lewy bodies.

21 January 2018

1 reference

Differential diagnosis of Alzheimer disease with cerebrospinal fluid levels of tau protein phosphorylated at threonine 231.

21 January 2018

1 reference

CSF phosphorylated tau protein correlates with neocortical neurofibrillary pathology in Alzheimer's disease.

21 January 2018

1 reference

Patterns of cerebral atrophy in dementia with Lewy bodies using voxel-based morphometry.

21 January 2018

1 reference

Cerebral atrophy in Parkinson's disease with and without dementia: a comparison with Alzheimer's disease, dementia with Lewy bodies and controls.

21 January 2018

1 reference

Dopaminergic degeneration and perfusional impairment in Lewy body dementia and Alzheimer's disease.

21 January 2018

1 reference

In vivo SPECT imaging of muscarinic acetylcholine receptors using (R,R) 123I-QNB in dementia with Lewy bodies and Parkinson's disease dementia.

21 January 2018

1 reference

A comparison of 99mTc-exametazime and 123I-FP-CIT SPECT imaging in the differential diagnosis of Alzheimer's disease and dementia with Lewy bodies.

21 January 2018

1 reference

Alterations in nicotinic α4β2 receptor binding in vascular dementia using ¹²³I-5IA-85380 SPECT: comparison with regional cerebral blood flow.

21 January 2018

1 reference

Atrophy of the putamen in dementia with Lewy bodies but not Alzheimer's disease: an MRI study

21 January 2018

1 reference

Clinical and pathologic features of two groups of patients with dementia with Lewy bodies: effect of coexisting Alzheimer-type lesion load.

21 January 2018

1 reference

Amyloid, hypometabolism, and cognition in Alzheimer disease: an [11C]PIB and [18F]FDG PET study.

21 January 2018

1 reference

Amyloid load in Parkinson's disease dementia and Lewy body dementia measured with [11C]PIB positron emission tomography.

21 January 2018

1 reference

Cardiac (123)I-metaiodobenzylguanidine imaging allows early identification of dementia with Lewy bodies during life

21 January 2018

1 reference

Differentiation of Alzheimer's disease from dementia with Lewy bodies utilizing positron emission tomography with [18F]fluorodeoxyglucose and neuropsychological testing

21 January 2018

1 reference

Cerebrospinal fluid markers in dementia with lewy bodies compared with Alzheimer disease

21 January 2018

1 reference

Imaging amyloid deposition in Lewy body diseases

21 January 2018

1 reference

Differentiation of dementia with Lewy bodies from Alzheimer's disease using Mini-Mental State Examination and brain perfusion SPECT.

21 January 2018

1 reference

The role of 123I-metaiodobenzylguanidine myocardial scintigraphy in the diagnosis of Lewy body disease in patients with dementia in a memory clinic

21 January 2018

1 reference

Comparative value of brain perfusion SPECT and [(123)I]MIBG myocardial scintigraphy in distinguishing between dementia with Lewy bodies and Alzheimer's disease

21 January 2018

1 reference

EFNS guidelines for the diagnosis and management of Alzheimer's disease.

21 January 2018

1 reference

Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease

21 January 2018

1 reference

Comparison of FDG-PET and IMP-SPECT in patients with dementia with Lewy bodies

21 January 2018

1 reference

Computer-assisted diagnostic system for neurodegenerative dementia using brain SPECT and 3D-SSP.

21 January 2018

1 reference

11C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairment

21 January 2018

1 reference

Differential levels of alpha-synuclein, beta-amyloid42 and tau in CSF between patients with dementia with Lewy bodies and Alzheimer's disease

21 January 2018

1 reference

Limitations of the HMPAO SPECT appearances of occipital lobe perfusion in the differential diagnosis of dementia with Lewy bodies.

21 January 2018

1 reference

The future of amyloid-beta imaging: a tale of radionuclides and tracer proliferation

21 January 2018

1 reference

Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B

21 January 2018

1 reference

Decreased cardiac MIBG uptake, its correlation with clinical symptoms in dementia with Lewy bodies

21 January 2018

1 reference

Differentiating Alzheimer's disease from dementia with Lewy bodies and Parkinson's disease with (+)-[11C]dihydrotetrabenazine positron emission tomography

21 January 2018

1 reference

The 18F-FDG PET cingulate island sign and comparison to 123I-beta-CIT SPECT for diagnosis of dementia with Lewy bodies

21 January 2018

1 reference

Occipital hypoperfusion on SPECT in dementia with Lewy bodies but not AD.

21 January 2018

1 reference

Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium

21 January 2018

1 reference

Sensitivity and specificity of dopamine transporter imaging with 123I-FP-CIT SPECT in dementia with Lewy bodies: a phase III, multicentre study.

21 January 2018

1 reference

Dementia with Lewy bodies and AD are not associated with occipital lobe atrophy on MRI.

21 January 2018

1 reference

Tau protein, Abeta42 and S-100B protein in cerebrospinal fluid of patients with dementia with Lewy bodies.

21 January 2018

1 reference

Follow-up investigations in cerebrospinal fluid of patients with dementia with Lewy bodies and Alzheimer's disease

21 January 2018

1 reference

Total tau protein, phosphorylated tau (181p) protein, beta-amyloid(1-42), and beta-amyloid(1-40) in cerebrospinal fluid of patients with dementia with Lewy bodies.

21 January 2018

1 reference

Direct quantification of CSF alpha-synuclein by ELISA and first cross-sectional study in patients with neurodegeneration

21 January 2018

1 reference

Multicenter standardized 18F-FDG PET diagnosis of mild cognitive impairment, Alzheimer's disease, and other dementias

21 January 2018

1 reference

Reliability of MIBG myocardial scintigraphy in the diagnosis of Parkinson's disease

21 January 2018

1 reference

Positron emission tomography: quantitative measurement of brain acetylcholinesterase activity using radiolabeled substrates

21 January 2018

1 reference

Amyloid imaging in Alzheimer's disease.

21 January 2018

1 reference

Myocardial (123)I-MIBG scintigraphy for differentiation of Lewy bodies disease from FTD.

21 January 2018

1 reference

Progressive brain atrophy on serial MRI in dementia with Lewy bodies, AD, and vascular dementia.

21 January 2018

1 reference

Dopamine transporter loss visualized with FP-CIT SPECT in the differential diagnosis of dementia with Lewy bodies.

21 January 2018

1 reference

Alpha4beta2 nicotinic receptor status in Alzheimer's disease using 123I-5IA-85380 single-photon-emission computed tomography

21 January 2018

1 reference

Nicotinic alpha4beta2 receptor binding in dementia with Lewy bodies using 123I-5IA-85380 SPECT demonstrates a link between occipital changes and visual hallucinations.

21 January 2018

1 reference

Diagnostic accuracy of 123I-FP-CIT SPECT in possible dementia with Lewy bodies.

21 January 2018

1 reference

CSF phosphorylated tau is a possible marker for discriminating Alzheimer's disease from dementia with Lewy bodies. Phospho-Tau International Study Group.

21 January 2018

1 reference

11C-PIB PET imaging in Alzheimer disease and frontotemporal lobar degeneration

21 January 2018

1 reference

Imaging beta-amyloid burden in aging and dementia.

21 January 2018

1 reference

Imaging of amyloid beta in Alzheimer's disease with 18F-BAY94-9172, a novel PET tracer: proof of mechanism

21 January 2018

1 reference

Reduced CSF CART in dementia with Lewy bodies

21 January 2018

1 reference

Mapping of brain acetylcholinesterase alterations in Lewy body disease by PET.

21 January 2018

1 reference

Differentiation of dementia with Lewy bodies from Alzheimer's disease using brain SPECT.

21 January 2018

1 reference

PET of brain amyloid and tau in mild cognitive impairment.

21 January 2018

1 reference

Diagnostic and Pathophysiological Impact of Myocardial MIBG Scintigraphy in Parkinson's Disease

21 January 2018

1 reference

FP-CIT and MIBG scintigraphy in early Parkinson's disease

21 January 2018

1 reference

Cerebrospinal fluid alpha-synuclein does not discriminate between dementia disorders.

21 January 2018

1 reference

Impaired myocardial 123I-metaiodobenzylguanidine uptake in Lewy body disease: comparison between dementia with Lewy bodies and Parkinson's disease.

21 January 2018

1 reference

Temporal lobe atrophy on MRI in Parkinson disease with dementia: a comparison with Alzheimer disease and dementia with Lewy bodies.

21 January 2018

1 reference

Comparison of the usefulness of brain perfusion SPECT and MIBG myocardial scintigraphy for the diagnosis of dementia with Lewy bodies

21 January 2018

1 reference

Cholinergic dysfunction in diseases with Lewy bodies.

21 January 2018

1 reference

Early and widespread cholinergic losses differentiate dementia with Lewy bodies from Alzheimer disease

21 January 2018

1 reference

Analytical performance and clinical utility of the INNOTEST PHOSPHO-TAU181P assay for discrimination between Alzheimer's disease and dementia with Lewy bodies.

21 January 2018

1 reference

Cerebrospinal fluid tau and beta-amyloid(1-42) in dementia disorders

21 January 2018

1 reference

Diagnostic markers for diagnosing dementia with Lewy bodies: CSF and MIBG cardiac scintigraphy study

21 January 2018

1 reference

Differentiation of dementia with Lewy bodies from Alzheimer's disease using a dopaminergic presynaptic ligand

21 January 2018

1 reference

Dementia with Lewy bodies: a comparison of clinical diagnosis, FP-CIT single photon emission computed tomography imaging and autopsy.

21 January 2018

1 reference

Cardiac (123)I-meta-iodobenzylguanidine (MIBG) uptake in dementia with Lewy bodies: comparison with Alzheimer's disease

21 January 2018

1 reference

Magnetic resonance imaging in lewy body dementias.

21 January 2018

1 reference

Focal atrophy in dementia with Lewy bodies on MRI: a distinct pattern from Alzheimer's disease

21 January 2018

1 reference

Rates of cerebral atrophy differ in different degenerative pathologies

21 January 2018

1 reference

A comparison of cerebral glucose metabolism in Parkinson's disease, Parkinson's disease dementia and dementia with Lewy bodies

21 January 2018

1 reference

A clinical role for [(123)I]MIBG myocardial scintigraphy in the distinction between dementia of the Alzheimer's-type and dementia with Lewy bodies

21 January 2018

1 reference

Dementia with Lewy bodies

21 January 2018

1 reference

Evaluation of CSF-tau and CSF-Abeta42 as diagnostic markers for Alzheimer disease in clinical practice

21 January 2018

1 reference

7 January 2021

18F-fluorodopa PET study of striatal dopamine uptake in the diagnosis of dementia with Lewy bodies

1 reference

7 January 2021

SIC Task Force appraisal of clinical diagnostic criteria for parkinsonian disorders

1 reference

7 January 2021

PIB is a non-specific imaging marker of amyloid-beta (Abeta) peptide-related cerebral amyloidosis

1 reference

7 January 2021

123I-MIBG cardiac scintigraphy provides clues to the underlying neurodegenerative disorder in idiopathic REM sleep behavior disorder

1 reference

7 January 2021

CSF alpha-synuclein levels in dementia with Lewy bodies and Alzheimer's disease

1 reference

7 January 2021

Usefulness of [123I]metaiodobenzylguanidine ([123I]MIBG) myocardial scintigraphy in differentiating between Alzheimer's disease and dementia with Lewy bodies

1 reference

7 January 2021

Identifiers

DOI

10.1002/GPS.2749

1 reference

release_hblidzdl7bhcpmgndsrhgmn5yy

25 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/hblidzdl7bhcpmgndsrhgmn5yy

24 November 2022

mapped directly with Wikidata item

1 reference